Opinion|Videos|May 3, 2024
Addressing Unmet Needs and Disease Progression Challenges in Pulmonary Arterial Hypertension Management
Author(s)Ioana Preston, MD
Ioana Preston, MD, discusses unmet needs in the management of pulmonary arterial hypertension (PAH) and the challenges associated with the progressive nature of the disease.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What are the major unmet needs in the management of pulmonary arterial hypertension (PAH) that contribute to high mortality and morbidity rates?
- How does the progressive nature of PAH pose challenges in maintaining long-term symptom control and slowing disease progression?
Advertisement
Related to this article
In experiments at MD Anderson, rising CD70 helps mantle cell lymphoma evade immunity; a CD70×CD3 bispecific restores T-cell killing and prolongs survival in resistant models.
The NPS index, ranging from –100 to +100, serves as a proxy for customers’ willingness to recommend products and services they themselves have used.
North Carolina experts discussed CLL, breast cancer, and myeloma treatments and how to expand access to complex cancer care beyond academic centers.
The IRA's Medicare out-of-pocket cap is easing costs for patients with cancer, but community oncology leaders warn price cuts are straining practices.
A survivor shares axi-cel therapy highs, experiences with severe CRS and neurotoxicity, and why access to care and clinical trials improves QOL.
Biomarker testing, referrals, screening, treatment access, and clinical trial barriers were examined during this recent IVBM.
Oncologists say advances in testing and treatment are outpacing staffing, pay, and access.
Home NB-UVB phototherapy matches office results, boosts psoriasis treatment adherence, and may improve access, but long-term safety, equity, and oversight lag.
Advertisement
Advertisement
Trending on AJMC
1
Tavapadon for Parkinson Disease Approved by FDA
2
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
3
Access and Innovation in North Carolina’s Research Triangle
4
Baricitinib Approved for Severe Alopecia Areata in Adolescents
5